Tech Company Financing Transactions

Recombinetics Funding Round

On 1/23/2013, Recombinetics landed $250 thousand in Series A investment from private investors.

Transaction Overview

Company Name
Announced On
1/23/2013
Transaction Type
Venture Equity
Amount
$250,000
Round
Series A
Investors
Proceeds Purpose
Recombinetics hopes to ramp up production to 600 diseased pigs per year by 2016.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1246 University Ave. W
Saint Paul, MN 55104
USA
Email Address
Not Recorded
Overview
At Recombinetics, we use unique precision genetics technologies to provide scientists who study persistent health risks -- obesity, diabetes, cancer, and high heart disease --with the research tools they need to understand and combat disease.
Profile
Recombinetics LinkedIn Company Profile
Social Media
Recombinetics Company Twitter Account
Company News
Recombinetics News
Facebook
Recombinetics on Facebook
YouTube
Recombinetics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tammy Lee
  Tammy Lee LinkedIn Profile  Tammy Lee Twitter Account  Tammy Lee News  Tammy Lee on Facebook
Chief Financial Officer
David Aberle
  David Aberle LinkedIn Profile  David Aberle Twitter Account  David Aberle News  David Aberle on Facebook
Chief Scientific Officer
Mitch Abrahamsen
  Mitch Abrahamsen LinkedIn Profile  Mitch Abrahamsen Twitter Account  Mitch Abrahamsen News  Mitch Abrahamsen on Facebook
Chief Scientific Officer
Tad Sonstegard
  Tad Sonstegard LinkedIn Profile  Tad Sonstegard Twitter Account  Tad Sonstegard News  Tad Sonstegard on Facebook
VP - Bus. Development
Justin Zenanko
  Justin Zenanko LinkedIn Profile  Justin Zenanko Twitter Account  Justin Zenanko News  Justin Zenanko on Facebook
VP - General Counsel
John Burtis
  John Burtis LinkedIn Profile  John Burtis Twitter Account  John Burtis News  John Burtis on Facebook
VP - R & D
Daniel Carlson
  Daniel Carlson LinkedIn Profile  Daniel Carlson Twitter Account  Daniel Carlson News  Daniel Carlson on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/23/2013: Cylene Pharmaceuticals venture capital transaction
Next: 1/23/2013: NetBase venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary